Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

The role of Platelet-Rich Plasma (PRP) intraarticular injections in restoring articular cartilage of osteoarthritic knees. A systematic review and meta-analysis

Prodromidis AD., Charalambous CP., Moran E., Venkatesh R., Pandit H.

Meta-analysis with a reported sample of 1099 on Knee Osteoarthritis, Osteoarthritis, published in Osteoarthr Cartil Open (2022) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Osteoarthr Cartil Open (2022)
Reported sample size
1099
Source database
Europe PMC
PMID
36474791
PMCID
PMC9718182
DOI
10.1016/j.ocarto.2022.100318
Citations
16

Abstract (original English)

Objective To assess the effect of PRP on knee articular cartilage content (thickness/volume) and examine the correlation between cartilage changes and clinical outcomes in patients with knee OA. Method A systematic literature search was performed using the Cochrane methodology in four online databases. Studies were included if they reported on cartilage content with cross-sectional imaging pre- and post-injection. A random-effects model meta-analysis was performed. Correlation with clinical outcomes was evaluated. Results 14 studies (n ​= ​1099 patients) from 1452 records met the inclusion criteria: seven RCTs (n ​= ​688), one prospective (n ​= ​50), one retrospective (n ​= ​68), and four case-series (n ​= ​224). The PRP preparation process and treatment protocol varied widely (follow-up 6-12 months). In meta-analysis, PRP treatment was not associated with a significant increase in cartilage thickness (4 studies, n ​= ​187, standardized mean difference: Hedges g: 0.079; 95%CI: 0.358 - 0.516; p ​= ​0.723). Meta-analysis of 3 RCTs (n ​= ​112) showed no significant difference in the change of overall knee cartilage content with PRP injections compared with no PRP (Hedges' g: 0.217; 95%CI: 0.177 - 0.611; P ​= ​0.281). Conclusion The current literature does not support the PRP as chondrogenic in treatment of knee OA. However, there is substantial heterogeneity in the evaluated studi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research